BrightSpring Health Services, Inc. (BTSG) KPIs and segments
Close on Nov 18, 2026Market cap $13.60BP/E 37.1Yield –
KPI & bộ phận
Chỉ số vận hành và bộ phận làm nên hoạt động của BrightSpring Health Services · năm tài chính kết thúc ngày 31 tháng 12
Nhìn nhanh KPI của BrightSpring Health Services: 44 chỉ số vận hành, trong đó có Prescriptions Dispensed, Revenue per Script và Gross Profit per Script, lấy từ 43 tài liệu nguồn, cùng doanh thu theo bộ phận, sản phẩm và khu vực từ hồ sơ SEC. Mỗi số đều dẫn tới tài liệu gốc. Tất cả chỉ số hiện cả bảng; Cốt lõi chỉ giữ bộ phận và KPI nổi bật. Bảng bộ phận còn có cách xem lũy kế 12 tháng.
Biểu đồ đang trống. Tick vào ô cạnh bất kỳ chỉ số nào ở bảng dưới để vẽ — tick nhiều chỉ số để so sánh trên cùng một biểu đồ.
Bộ phận, KPI nổi bật và mọi chỉ số vận hành từ hồ sơ, thông cáo kết quả và bản trình bày.
| Thêm vào biểu đồ | Chỉ số | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharmacy Solutions($M)8 | 3,732 | 3,407 | 3,171 | 3,157 | 2,967 | 2,790 | 2,532 | 2,397 | 2,266 | 2,115 | 1,977 | 1,786 | |
Products($M) | 3,732 | 3,407 | 3,171 | 3,157 | 2,967 | 2,790 | 2,532 | 2,397 | 2,266 | 2,114 | 1,977 | ||
Medicare Part D($M) | 1,247 | 1,150 | 1,074 | 1,120 | 1,058 | 1,008 | 911 | 850 | 826 | 770 | 756 | 516 | |
Commercial Insurance($M) | 1,184 | 1,054 | 959 | 880 | 818 | 742 | 675 | 666 | 619 | 570 | 504 | 468 | |
Medicare Part C($M) | 708 | 654 | 602 | 641 | 593 | 556 | 488 | 426 | 406 | 378 | 337 | 418 | |
Medicaid($M) | 376 | 339 | 309 | 301 | 287 | 266 | 238 | 228 | 214 | 200 | 187 | 178 | |
Medicare Part A($M) | 135 | 136 | 138 | 151 | 143 | 139 | 140 | 147 | 142 | 128 | 129 | 139 | |
Private and Other($M) | 64 | 56.1 | 68.8 | 44.1 | 48.2 | 60.3 | 61 | 59.6 | 41.7 | 52.3 | 45.8 | 49.9 | |
Medicare Part B($M) | 18.1 | 18.3 | 20.3 | 19.5 | 18.7 | 18.7 | 19.5 | 19.9 | 16.8 | 16.7 | 16.9 | 16.1 | |
Provider Services($M)8 | 481 | 466 | 442 | 394 | 367 | 358 | 346 | 350 | 336 | 324 | 309 | 589 | |
Services($M) | 481 | 466 | 442 | 394 | 367 | 358 | 346 | 350 | 336 | 324 | 309 | ||
Medicare Part A($M) | 184 | 174 | 171 | 146 | 127 | 126 | 122 | 126 | 114 | 108 | 105 | 106 | |
Medicaid($M) | 106 | 97.3 | 97.1 | 100 | 128 | 88.5 | 85.1 | 86 | 84.9 | 83.9 | 82.7 | 336 | |
Medicare Part C($M) | 66.9 | 66.8 | 64.6 | 39.6 | 28.8 | 34.6 | 32.6 | 33.6 | 36 | 28.1 | 20.2 | 21.6 | |
Commercial Insurance($M) | 61.3 | 59 | 54.9 | 51.9 | 51.3 | 44.1 | 41.4 | 43.1 | 41.9 | 41.9 | 41.1 | 37.2 | |
Private and Other($M) | 58.9 | 57.1 | 53.1 | 54.4 | 30 | 63.2 | 62.9 | 54.3 | 54.7 | 54.1 | 52.6 | 81.7 | |
Medicare Part B($M) | 3.60 | 12.3 | 1.50 | 1.80 | 1.70 | 1.40 | 1.50 | 6.90 | 3.70 | 8.10 | 6.90 | 5.70 | |
Medicare Part D($M) | 0.40 | ||||||||||||
Products($M) | 3,732 | 3,407 | 3,171 | 3,157 | 2,967 | 2,790 | 2,532 | 2,397 | 2,266 | 2,114 | 1,977 | 1,785 | |
Medicare Part D($M) | 1,247 | 1,150 | 1,074 | 1,120 | 1,058 | 1,008 | 911 | 850 | 826 | 770 | 756 | 516 | |
Commercial Insurance($M) | 1,246 | 1,113 | 1,014 | 932 | 870 | 786 | 716 | 709 | 661 | 612 | 546 | 505 | |
Medicare Part C($M) | 775 | 721 | 667 | 681 | 622 | 590 | 520 | 460 | 442 | 406 | 357 | 439 | |
Medicaid($M) | 482 | 437 | 406 | 402 | 416 | 355 | 323 | 314 | 299 | 284 | 270 | 514 | |
Services($M) | 481 | 466 | 442 | 394 | 367 | 358 | 346 | 350 | 336 | 324 | 309 | 589 | |
Medicare Part A($M) | 319 | 310 | 309 | 297 | 270 | 265 | 263 | 273 | 256 | 235 | 235 | 245 | |
Private and Other($M) | 123 | 113 | 122 | 98.5 | 78.2 | 124 | 124 | 114 | 96.4 | 106 | 98.4 | 132 | |
Medicare Part B($M) | 21.7 | 30.6 | 21.8 | 21.3 | 20.4 | 20.1 | 21 | 26.8 | 20.5 | 24.8 | 23.8 | 21.7 | |
Kỳ báo cáo trước đây (báo cáo lần cuối 2026)2 | |||||||||||||
Prescriptions Dispensed2 | 10,949,875 | 10,844,038 | 10,729,876 | 10,844,786 | 10,793,219 | 10,851,773 | 10,877,294 | 10,967,463 | 10,874,429 | 10,120,197 | 9,854,495 | 9,590,754 | |
Prescriptions Dispensed — YoY Growth(%) | 1.5% | -0.1% | -1.4% | -1.0% | -0.7% | 7.2% | 10.4% | 14.5% | 9.1% | 9.2% | |||
Specialty & Infusion Script Volume — YoY Growth(%) | 29.0% | 31.0% | 30.0% | 30.0% | |||||||||
Revenue per Script($)1 | 341 | 314 | 296 | 291 | 275 | 257 | 233 | 219 | 208 | 209 | 201 | ||
Revenue per Script — YoY Growth(%) | 24.0% | 22.2% | 27.0% | 33.0% | 31.9% | 23.1% | 16.0% | 18.3% | 21.3% | 23.5% | |||
Gross Profit per Script($)1 | 28.86 | 27.50 | 28.03 | 23.52 | 22.76 | 21.54 | 18.75 | 18.65 | 17.34 | 18.06 | 17.24 | ||
Gross Profit per Script — YoY Growth(%) | 26.8% | 27.7% | 49.5% | 26.0% | 31.3% | 19.3% | 8.8% | 0.9% | -10.7% | -2.8% | |||
Limited Distribution Drugs (LDDs) — Total Portfolio Supported | 162 | 155 | 153 | 149 | |||||||||
Specialty Pharmacy Medication Possession Ratio (MPR)(%)1 | 93.0% | 93.0% | 92.1% | 92.4% | |||||||||
Specialty Pharmacy Average Time to First Fill(ngày) | 4 | 4 | 5 | 4 | |||||||||
Home & Community Pharmacy Order Completeness Rate(%)1 | 98.2% | 99.0% | 99.0% | 99.3% | |||||||||
Home & Community Pharmacy On-Time Delivery Rate(%) | 91.9% | 94.3% | 96.0% | 96.8% | |||||||||
Home Health Care Average Daily Census (ADC)3 | 47,256 | 46,448 | 46,066 | 34,593 | 29,980 | 30,085 | 30,241 | 30,019 | 28,650 | 28,280 | 27,093 | ||
Home Health Care ADC — YoY Growth(%) | 57.6% | 54.4% | 52.3% | 15.0% | 3.3% | 6.4% | 11.6% | ||||||
Home Health Branches Rated 4+ CMS Quality Stars(%) | 96.0% | 93.2% | 91.4% | ||||||||||
Home Health Timely Initiation of Care Rate(%) | 99.0% | 98.9% | 99.2% | 99.4% | |||||||||
Rehab Care Persons Served1 | 7,574 | 7,755 | 7,620 | 7,363 | 6,932 | 7,119 | 6,697 | 6,544 | 6,571 | 6,728 | 6,546 | ||
Rehab Care Persons Served — YoY Growth(%) | 9.3% | 8.9% | 13.8% | 13.0% | 11.4% | 5.8% | 2.3% | ||||||
Personal Care Persons Served2 | 16,320 | 16,357 | 16,079 | 16,175 | 16,134 | 16,138 | 15,863 | 15,874 | 15,910 | 15,932 | 15,798 | ||
Personal Care Persons Served — YoY Growth(%) | 1.2% | 1.4% | 1.4% | 2.0% | 1.4% | 1.3% | 0.4% | ||||||
Personal Care Client Satisfaction Score (Out of 5.0)(×) | 4.60 | 4.60 | 4.60 | 4.60 | 4.50 | ||||||||
Hospice CAHPS Overall Care Rating(%) | 86.0% | 89.0% | 87.0% | 87.0% | |||||||||
Clinical Providers & Pharmacists (Continuing Operations) | 12,700 | 12,700 | 12,400 | 10,500 | 10,500 | 10,000 | |||||||
Specialty & Infusion Pharmacy Revenue($M)1 | 3,180 | 2,868 | 2,644 | 2,564 | 2,377 | 2,203 | 1,952 | 1,796 | 1,678 | 1,586 | 1,466 | 1,270 | |
Specialty & Infusion Share of Consolidated Revenue(%) | 75.5% | 74.1% | 73.2% | 71.3% | 70.0% | 67.7% | 64.5% | 65.1% | 64.2% | ||||
Home & Community Pharmacy Revenue($M)2 | 553 | 540 | 527 | 593 | 590 | 587 | 581 | 601 | 588 | 528 | 511 | 516 | |
Home & Community Pharmacy Share of Consolidated Revenue(%) | 13.1% | 13.9% | 14.6% | 17.7% | 18.6% | 20.3% | 22.6% | 21.6% | 22.3% | ||||
Total Pharmacy Solutions Share of Consolidated Revenue(%) | 88.6% | 88.0% | 87.8% | 89.0% | 88.6% | 88.0% | 87.1% | 86.7% | 86.5% | ||||
Pharmacy Solutions Segment Gross Profit($M)1 | 316 | 298 | 301 | 255 | 246 | 234 | 204 | 205 | 189 | 183 | 170 | 171 | |
Pharmacy Solutions Segment Gross Margin(%) | 8.5% | 8.8% | 9.5% | 8.3% | 8.4% | 8.1% | 8.3% | 8.6% | 8.6% | ||||
Home Health Care Sub-Segment Revenue($M)2 | 288 | 278 | 266 | 215 | 189 | 185 | 178 | 182 | 168 | 158 | 148 | ||
Acquired Amedisys & LHC Branches Revenue Contribution($M) | 76 | 78 | 79 | ||||||||||
Home Health Care Share of Consolidated Revenue(%) | 6.9% | 7.2% | 7.3% | 5.6% | 5.9% | 6.2% | 6.5% | 6.5% | 6.6% | ||||
Rehab Care Sub-Segment Revenue($M)1 | 81.8 | 81.9 | 74.8 | 76.8 | 75.5 | 73.2 | 69.8 | 69.7 | 70.2 | 70 | 66.7 | ||
Rehab Care Share of Consolidated Revenue(%) | 1.9% | 2.1% | 2.1% | 2.3% | 2.3% | 2.4% | 2.6% | 2.8% | 2.8% | ||||
Personal Care Sub-Segment Revenue($M)2 | 111 | 107 | 102 | 102 | 102 | 99.9 | 97.7 | 98.1 | 97.1 | 96.2 | 94.5 | ||
Personal Care Share of Consolidated Revenue(%) | 2.6% | 2.7% | 2.8% | 3.1% | 3.2% | 3.4% | 3.8% | 4.0% | 4.1% | ||||
Total Provider Services Share of Consolidated Revenue(%) | 11.4% | 12.0% | 12.2% | 11.0% | 11.4% | 12.0% | 12.9% | 13.3% | 13.5% | ||||
Consolidated Adjusted EBITDA (Continuing Operations)($M)2 | 228 | 206 | 190 | 184 | 160 | 143 | 131 | 130 | 117 | 111 | 102 | ||
Total Segment EBITDA($M)2 | 281 | 255 | 235 | 227 | 202 | 181 | 167 | 168 | 151 | 145 | 135 | ||
Pharmacy Solutions Segment EBITDA($M) | 202 | 180 | 169 | 162 | 141 | 125 | 116 | 113 | 99.2 | 94.5 | 88.2 | ||
Provider Services Segment EBITDA($M) | 79 | 74.9 | 66 | 64.4 | 60.7 | 56.5 | 51.1 | 55.6 | 52.3 | 50.7 | 46.8 | ||
Unallocated Corporate Costs (EBITDA Reconciliation)($M) | 53 | 49 | 45 | 43 | 41 | 39 | 36 | 38 | 34 | 34 | 33 | ||
Pharmacy Solutions Segment Operating Income($M)2 | 176 | 155 | 144 | 136 | 115 | 97.7 | 88.2 | 84.1 | 71.2 | 67.3 | 60.9 | 63.7 | |
Pharmacy Solutions Segment SG&A Expenses($M) | 140 | 144 | 157 | 119 | 131 | 136 | 116 | 120 | 117 | 116 | 109 | ||
Pharmacy Solutions Segment Depreciation & Amortization($M) | 25.8 | 25.5 | 25.3 | 26.2 | 26.5 | 27 | 27.5 | 28.7 | 27.9 | 27.2 | 27.2 | ||
Provider Services Segment Operating Income (Continuing Operations)($M)2 | 74 | 66 | 59 | 58.3 | 53.3 | 49.3 | 44.3 | 48.9 | 46 | 44.7 | 41 | ||
Provider Services Segment SG&A Expenses($M) | 129 | 129 | 122 | 99.3 | 93 | 91.9 | 90.1 | 85.3 | 88.5 | 84.7 | 81.5 | ||
Provider Services Segment Depreciation & Amortization($M) | 5 | 8.80 | 7 | 6.20 | 7.30 | 7.20 | 6.80 | 6.70 | 6.30 | 6 | 5.70 | ||
Adjusted Diluted Earnings per Share (Adjusted EPS)($) | 0.54 | 0.45 | 0.39 | 0.33 | 0.30 | 0.22 | 0.19 | 0.13 | 0.03 | 0.06 | 0.09 | ||
Top 10 Operating States Share of Consolidated Revenue(%)1 | 52.0% | 53.0% | 52.0% | 53.0% | 53.0% | 53.0% | 52.0% | 52.0% | 54.0% | ||||
Top 10 Medicaid States Share of Consolidated Revenue(%) | 7.0% | 7.0% | 6.0% | 7.0% | 6.0% | 6.0% | 7.0% | 7.0% | 7.0% | ||||
Full-Year Total Revenue Guidance — Low End (Issued in Quarter)($M)7 | 15,900 | 15,100 | 14,725 | 14,450 | 12,500 | 12,200 | 12,000 | ||||||
Full-Year Total Revenue Guidance — High End($M) | 16,125 | 15,425 | 15,225 | 15,000 | 12,800 | 12,600 | 12,500 | ||||||
Full-Year Pharmacy Revenue Guidance — Low End($M) | 14,000 | 13,200 | 12,850 | 12,600 | 11,050 | 10,750 | 10,550 | ||||||
Full-Year Pharmacy Revenue Guidance — High End($M) | 14,200 | 13,500 | 13,300 | 13,100 | 11,300 | 11,100 | 11,000 | ||||||
Full-Year Provider Revenue Guidance — Low End($M) | 1,900 | 1,900 | 1,875 | 1,850 | 1,450 | 1,450 | 1,450 | ||||||
Full-Year Provider Revenue Guidance — High End($M) | 1,925 | 1,925 | 1,925 | 1,900 | 1,500 | 1,500 | 1,500 | ||||||
Full-Year Adjusted EBITDA Guidance — Low End($M) | 850 | 820 | 795 | 760 | 605 | 590 | 570 | ||||||
Full-Year Adjusted EBITDA Guidance — High End($M) | 860 | 845 | 825 | 790 | 615 | 605 | 585 | ||||||
Credit Agreement Net Leverage Ratio(×) | 1.79 | 2.15 | 2.27 | 2.99 | 3.31 | 3.64 | 3.87 | 4.16 | 4.39 | 4.51 | 4.33 | 5.86 | |
Total Available Liquidity (Period-End)($M)2 | 1,194 | 1,027 | 1,366 | 566 | 618 | 548 | 531 | 476 | 417 | 437 | 526 | 431 | |
Revolving Credit & LC Facility Availability($M) | 476 | 476 | 477 | 477 | 477 | 478 | 478 | 415 | 381 | 412 | 468 | 418 | |
Outstanding Letters of Credit under LC Facility($M) | 63.9 | 63.9 | 62.9 | 62.8 | 62.8 | 61.8 | 61.8 | 61.8 | -62 | -54.2 | -54.3 | 54.3 | |
Goodwill — Pharmacy Solutions Segment($M)1 | 841 | 841 | 841 | 841 | 841 | 841 | 841 | 841 | 841 | 841 | 835 | 834 | |
Goodwill — Provider Services Segment($M) | 1,696 | 1,694 | 1,693 | 1,705 | 1,530 | 1,529 | 1,529 | 1,523 | 1,832 | 1,785 | 1,774 | 1,467 | |
Indefinite-Lived Healthcare Licenses & Certificates of Need($M)1 | 192 | 192 | 193 | 193 | 137 | 136 | 136 | 136 | 135 | 118 | 118 | 118 | |
Finite-Lived Intangible Assets, Net($M)6 | 300 | 323 | 344 | 364 | 384 | 409 | 433 | 460 | 708 | 733 | 738 | 763 | |
Customer Relationships, Net($M) | 106 | 120 | 133 | 146 | 163 | 177 | 192 | 207 | 321 | 339 | 339 | 353 | |
Trade Names, Net($M) | 146 | 153 | 159 | 164 | 173 | 180 | 187 | 193 | 200 | 201 | 207 | 212 | |
Doctor & Payor Relationships, Net($M) | 0.30 | 0.40 | 0.50 | 0.70 | 0.80 | 1 | 1.20 | 1.80 | 2.30 | 2.80 | 3.40 | 3.90 | |
Licensing Agreements, Net($M) | 44.9 | 46.1 | 47.4 | 48.5 | 42.5 | 44.6 | 46 | 50.9 | 176 | 180 | 178 | 183 | |
Non-Compete Agreements, Net($M) | 1.50 | 1.40 | 1.60 | 1.90 | 2.30 | 2.50 | 2.90 | 2.90 | 3.40 | 4.10 | 4.30 | 4.60 | |
Other Finite-Lived Intangible Assets, Net($M) | 1.80 | 2.20 | 2.60 | 3 | 3.40 | 3.80 | 4.20 | 4.60 | 5 | 5.40 | 5.80 | 6.10 | |
Option Care Health, Inc. (OPCH — Home & Alternate-Site Infusion) — Consolidated Revenue($M)1 | 1,494 | 1,442 | 1,351 | 1,465 | 1,435 | 1,416 | 1,333 | 1,346 | 1,279 | 1,227 | 1,146 | 1,124 | |
Option Care Health, Inc. — Operating Income($M) | 89 | 85 | 73 | 92 | 85 | 83 | 79 | 87 | 85 | 81 | 69 | 85 | |
Chemed Corporation (CHE — VITAS Hospice) — Consolidated Revenue($M)1 | 691 | 673 | 658 | 639 | 625 | 619 | 647 | 640 | 606 | 596 | 589 | 586 | |
Chemed Corporation — Operating Income($M) | 96 | 89 | 85 | 101 | 75 | 68 | 95 | 114 | 92 | 88 | 72 | 111 | |
The Pennant Group, Inc. (PNTG — Home Health, Hospice & Senior Living) — Consolidated Revenue($M)1 | 302 | 298 | 285 | 289 | 229 | 220 | 210 | 189 | 181 | 169 | 157 | 146 | |
The Pennant Group, Inc. — Operating Income($M) | 17 | 17 | 17 | 17 | 10 | 12 | 13 | 9 | 11 | 10 | 9 | 8 | |
Addus HomeCare Corporation (ADUS — Personal Care, Hospice & Home Health) — Consolidated Revenue($M)1 | 388 | 377 | 364 | 373 | 362 | 349 | 338 | 297 | 290 | 287 | 281 | 276 | |
Addus HomeCare Corporation — Operating Income($M) | 40 | 39 | 34 | 42 | 33 | 33 | 31 | 27 | 26 | 26 | 24 | 28 | |
The Ensign Group, Inc. (ENSG — Post-Acute & Skilled Nursing) — Consolidated Revenue($M)1 | 1,484 | 1,440 | 1,389 | 1,361 | 1,296 | 1,228 | 1,173 | 1,132 | 1,082 | 1,036 | 1,010 | 959 | |
The Ensign Group, Inc. — Operating Income($M) | 138 | 123 | 125 | 124 | 96 | 104 | 101 | 101 | 89 | 86 | 82 | 23 | |
Encompass Health Corporation (EHC — Inpatient & Post-Acute Rehabilitation) — Consolidated Revenue($M) | 1,610 | 1,597 | 1,587 | 1,545 | 1,478 | 1,458 | 1,455 | 1,405 | 1,351 | 1,301 | 1,316 | 1,247 | |
Consolidated Net Revenue($M)3 | 4,213 | 3,873 | 3,614 | 3,551 | 3,334 | 3,148 | 2,878 | 2,747 | 2,601 | 2,438 | 2,286 | 1,239 | |
Consolidated Gross Profit($M) | 519 | 493 | 482 | 413 | 392 | 375 | 338 | 339 | 323 | 312 | 293 | 73.9 | |
Selling, General and Administrative Expenses($M) | 358 | 362 | 361 | 304 | 304 | 326 | 288 | 283 | 294 | 274 | 308 | 94.7 | |
Consolidated Operating Income($M) | 161 | 130 | 121 | 108 | 87.8 | 48.6 | 50.7 | 55.5 | 29.1 | 38.7 | -15.3 | -20.8 | |
Income (Loss) from Continuing Operations($M)3 | 101 | 86.7 | 74.4 | 49.3 | 38.1 | 9.20 | 9.70 | 4.90 | -24.9 | 9 | -55.4 | ||
Income (Loss) from Discontinued Operations, Net of Tax($M) | -0.50 | -2.40 | 74.3 | 27.8 | 17.8 | 19 | 19.8 | 11.1 | 16.7 | 11 | 9.60 | ||
Net Income (Loss) Attributable to BrightSpring Health Services, Inc.($M) | 100 | 84.3 | 149 | 77.1 | 55.8 | 28.2 | 29.5 | 16 | -8.20 | 19.9 | -45.8 | -6.50 | |
GAAP Diluted Earnings (Loss) per Common Share($) | 0.45 | 0.38 | 0.67 | 0.26 | 0.13 | 0.14 | -0.04 | 0.10 | -0.26 | ||||
Total Consolidated Assets($M)6 | 6,267 | 5,986 | 6,213 | 6,413 | 6,050 | 5,944 | 5,847 | 5,926 | 5,786 | 5,605 | 5,656 | 5,533 | |
Cash and Cash Equivalents($M) | 718 | 550 | 889 | 88.4 | 140 | 70.1 | 52.3 | 61 | 35.5 | 22.8 | 55.5 | 12.4 | |
Accounts Receivable, Net($M) | 1,216 | 1,139 | 1,114 | 990 | 1,013 | 973 | 975 | 903 | 1,026 | 985 | 991 | 882 | |
Inventories($M) | 672 | 575 | 560 | 815 | 639 | 626 | 534 | 637 | 478 | 374 | 374 | 403 | |
Goodwill (Consolidated)($M) | 2,537 | 2,535 | 2,534 | 2,546 | 2,371 | 2,370 | 2,370 | 2,364 | 2,673 | 2,626 | 2,609 | 2,301 | |
Intangible Assets, Net (Consolidated)($M) | 492 | 514 | 537 | 558 | 522 | 544 | 568 | 595 | 843 | 851 | 856 | 882 | |
Operating Lease Right-of-Use Assets($M) | 170 | 167 | 173 | 172 | 160 | 164 | 162 | 161 | 259 | 259 | 276 | 267 | |
Total Consolidated Debt4 | |||||||||||||
Long-Term Debt, Net of Current Portion($M) | 2,147 | 2,149 | 2,445 | 2,455 | 2,465 | 2,478 | 2,489 | 2,562 | 2,609 | 2,564 | 2,515 | 3,332 | |
Total Consolidated Liabilities($M) | 4,081 | 3,928 | 4,223 | 4,527 | 4,229 | 4,198 | 4,156 | 4,275 | 4,167 | 3,999 | 4,081 | 4,920 | |
Total Stockholders' Equity($M) | 2,177 | 2,049 | 1,979 | 1,875 | 1,819 | 1,743 | 1,687 | 1,648 | 1,615 | 1,600 | 1,568 | 585 | |
Common Shares Outstanding (Period-End)(M) | 199 | 198 | 193 | 192 | 181 | 177 | 175 | 174 | 174 | 171 | 171 | 118 | |
Net Cash Provided by (Used in) Operating Activities($M)2 | 204 | 43.9 | 123 | 232 | 108 | 49.1 | 102 | 90.6 | 27.2 | -15.2 | -78.9 | 162 | |
Capital Expenditures (Purchases of Property and Equipment)($M) | 22.1 | 29 | 21.5 | 37.7 | 15.8 | 24.4 | 17.6 | 15.3 | 20 | 23.7 | 21.8 | 16.8 | |
Cash Paid for Acquisitions, Net of Cash Acquired($M) | 1.90 | -0 | 42.2 | 196 | 1.60 | -0 | 6.80 | 0 | 16.1 | 34.2 | 9.40 | 0.50 | |
In nghiêng là số StockData tự tính từ số đã báo cáo (rê chuột để xem công thức). Số có gạch chân chấm là số đọc từ câu chữ trong thông cáo kết quả và bản trình bày; rê chuột để xem đúng câu đó. Tick vào một dòng để thêm vào biểu đồ phía trên (tối đa 8 đường).
Phương pháp và các chỉ số bị loại
- Các dòng ở Cốt lõi lấy từ thuyết minh bộ phận và phân tách doanh thu trong hồ sơ 10-K và 10-Q (XBRL), có liên kết tới từng hồ sơ. Số quý 4 bằng cả năm tài chính trừ chín tháng đầu (hiện bằng chữ in nghiêng).
- Fiscal Calendar & Reporting Scope: BrightSpring Health Services, Inc. operates on a calendar fiscal year ending December 31 (Q1 ends March 31, Q2 ends June 30, Q3 ends September 30, Q4 ends December 31). Latest company filings included: Q3 2026 Form 10-Q and Form 8-K Item 2.02 (ended September 30, 2026, filed October 30, 2026), Q3 2026 Earnings Call Transcript, 2026 Clinical Quality Reports, 2026 Definitive Proxy Statement (DEF 14A), and FY2025 Form 10-K (ended December 31, 2025, filed February 27, 2026). External BLS Producer Price Index and Employment series are updated monthly through October 2026 (2026-10), one month ahead of Q3 2026 company filings.
- Continuing Operations & Segment Realignment: On January 20, 2025, BrightSpring entered into a definitive agreement to divest its Community Living business to Sevita, which closed on March 30, 2026 ($835.0 million gross cash consideration; $810.9 million cash proceeds). Provider Services operational metrics, sub-segment revenues, and consolidated Non-GAAP measures are presented on a continuing-operations basis from Q1 2024 / FY2023 forward (Home Health Care, Rehab Care, and Personal Care). Pharmacy Solutions was unaffected by the Community Living divestiture and spans FY2020–FY2025 and Q4 2022–Q3 2026. Effective July 1, 2026, the Rehab in Motion business shifted from Rehab Care to Home Health Care with Q3 2025 and 9M 2025 comparables recast.
- Parent-Company Schedule I Evaluation: Under U.S. GAAP, BrightSpring Health Services, Inc. is a holding company with no standalone operating revenue or operational volume disclosures outside consolidated subsidiaries; condensed parent-only financial information (Schedule I) is an annual holding-company equity summary, so Consolidated minus Parent-Only subtraction does not apply.
- Data Integrity & Permitted Period Splits: Every cell presents an exact published figure from BrightSpring SEC filings, earnings call transcripts, clinical quality reports, or official U.S. statistical/regulatory agencies (BLS, U.S. Census Bureau, and peer SEC XBRL filings), plus permitted standalone-quarter subtractions from cumulative year-to-date disclosures (Q4 = full year − nine months and cash flow year-to-date splits, explicitly annotated with formula). Directional bounds ('over 23,500 FTEs', 'over 485,000 patients daily', 'over 175 pharmacies') are excluded from numeric cells.
Không hiện vì thiếu các kỳ gần đây (7)
- Total Employees / FTE Headcount, Daily Patients Served, Pharmacy Locations & Customer Contracts (disclosed primarily as directional bounds such as 'over 23,500 FTEs', 'over 485,000 patients daily', 'over 175 pharmacies, infusion centers, and specialty oncology clinics', and 'over 4,500 contracts', which are ineligible as point values)
- Union-Represented FTE Headcount & Owned/Leased Property Counts across 2023–2025 Form 10-Ks (subject to an un-recast scope break at year-end 2025 when Community Living was reclassified to held-for-sale / discontinued operations, reducing union FTEs from ~7,200 total company in FY2024 to ~3,500 continuing operations in FY2025)
- Pre-Divestiture Provider Services Metrics — Historical Community and Rehab Care Persons Served & Pre-Recast Home Health Care ADC including Personal Care (superseded in Q1 2025 upon the Community Living divestiture agreement and recast into continuing-operations Home Health Care ADC, Rehab Care Persons Served, and Personal Care Persons Served)
- Home & Community Pharmacy Dispensing Accuracy Rate on Quarterly Calls (reported for Q4 2025, Q1 2026, and Q2 2026 at 99.98%–99.99%, but omitted on the Q3 2026 earnings call; annual enterprise pharmacy order accuracy from Form 10-K is retained in Group 1)
- Quarterly Branded LDD Launch Counts on Earnings Calls (management alternated between total LDD launches in Q4 2025 and Q3 2026 versus narrow 'exclusive / ultra-narrow LDDs added' in Q1 2026 and Q2 2026; period-end Total LDD Portfolio Supported is consistent across all four quarters and retained in Group 1)
- U.S. Census Bureau Quarterly Services Survey — Home Health Care Services Revenue (FRED REV6216TAXABL144QNSA; publication paused after Q1 2025 with missing 2024 quarters, replaced by continuous monthly BLS Home Health PPI and Employment through October 2026)
- Aveanna Healthcare Holdings Inc. (AVAH) XBRL Series & Encompass Health (EHC) Operating Income (Aveanna uses a non-calendar 52/53-week fiscal year causing fiscal quarter key misalignment against BrightSpring's December 31 calendar quarters, and Encompass Health changed its XBRL operating income tag after FY2022)
Dữ liệu cập nhật 2026-11-14.
Mỗi KPI một trang riêng
Đầy đủ lịch sử, biểu đồ, nguồn và cách trích dẫn cho từng chỉ số
Pharmacy Solutions Operating Metrics
Provider Services Operating Metrics (Continuing Operations)
Sub-Segment Revenue Mix, Segment Profitability & Guidance
- Specialty & Infusion Pharmacy Revenue ($M)16 kỳ
- Home & Community Pharmacy Revenue ($M)16 kỳ
- Pharmacy Solutions Segment Gross Profit ($M)16 kỳ
- Home Health Care Sub-Segment Revenue ($M)11 kỳ
- Rehab Care Sub-Segment Revenue ($M)11 kỳ
- Personal Care Sub-Segment Revenue ($M)11 kỳ
- Consolidated Adjusted EBITDA (Continuing Operations) ($M)11 kỳ
- Pharmacy Solutions Segment Operating Income ($M)16 kỳ
- Provider Services Segment Operating Income (Continuing Operations) ($M)11 kỳ
- Adjusted Diluted Earnings per Share (Adjusted EPS) ($)11 kỳ
- Top 10 Operating States Share of Consolidated Revenue (%)9 kỳ
- Full-Year Total Revenue Guidance — Low End (Issued in Quarter) ($M)7 kỳ
Liquidity, Leverage, Leases & Asset Composition
- Credit Agreement Net Leverage Ratio (×)12 kỳ
- Total Available Liquidity (Period-End) ($M)12 kỳ
- Goodwill — Pharmacy Solutions Segment ($M)13 kỳ
- Indefinite-Lived Healthcare Licenses & Certificates of Need ($M)12 kỳ
- Property and Equipment, Gross (Continuing Operations) ($M)2 kỳ
- Operating Lease Undiscounted Future Payments — Total ($M)2 kỳ
Industry Macro Indicators (BLS / Census) & Specialty Infusion / Home-Based Care Peers
- BLS PPI — U.S. Home Health Care Services (PCU621610621610, Index) (×)70 kỳ
- BLS Employment — U.S. Home Health Care Services (CES6562160001) (M)70 kỳ
- BLS PPI — U.S. Pharmacies and Drug Stores (PCU446110446110, Index) (×)70 kỳ
- U.S. Census Retail Sales — Pharmacies and Drug Stores (MRTSSM44611USS, SA) ($M)68 kỳ
- Option Care Health, Inc. (OPCH — Home & Alternate-Site Infusion) — Consolidated Revenue ($M)23 kỳ
- Chemed Corporation (CHE — VITAS Hospice) — Consolidated Revenue ($M)23 kỳ
- The Pennant Group, Inc. (PNTG — Home Health, Hospice & Senior Living) — Consolidated Revenue ($M)23 kỳ
- Addus HomeCare Corporation (ADUS — Personal Care, Hospice & Home Health) — Consolidated Revenue ($M)23 kỳ
- The Ensign Group, Inc. (ENSG — Post-Acute & Skilled Nursing) — Consolidated Revenue ($M)23 kỳ
- Encompass Health Corporation (EHC — Inpatient & Post-Acute Rehabilitation) — Consolidated Revenue ($M)23 kỳ
Consolidated Financial Statements Context (Income Statement, Balance Sheet & Cash Flows)
Tài liệu nguồn mới nhất
Các tài liệu được trích nhiều nhất cho số liệu mới nhất của BrightSpring Health Services
- BrightSpring 10-Q (2026-10-30) ↗
- BrightSpring 10-K (2026-02-27) ↗
- BrightSpring Q3 2026 Earnings Call Transcript (2026-10-30) ↗
- BrightSpring 2026 Annual Clinical Quality Report (2026-03-15) ↗
- BrightSpring 8-K (2026-10-30) ↗
- BrightSpring Q4 2025 Earnings Call Transcript (2026-02-27) ↗
- BrightSpring 8-K (2026-02-27) ↗
- U.S. Bureau of Labor Statistics PPI / FRED (PCU621610621610) ↗
- U.S. Bureau of Labor Statistics CES / FRED (CES6562160001) ↗
- BLS / FRED (PCU446110446110) ↗
- U.S. Census Bureau / FRED (MRTSSM44611USS) ↗
- Option Care Health, Inc. SEC 10-Q (XBRL) ↗
See a number that looks wrong?